Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Infection

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43865   clinical trials with a EudraCT protocol, of which   7286   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    5,271 result(s) found for: Infection. Displaying page 1 of 264.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2017-002669-23 Sponsor Protocol Number: PROFITOP Start Date*: 2017-12-21
    Sponsor Name:Hospital General Universitari de Granollers
    Full Title: Prophylaxis of surgical wound infection with topical antibiotics
    Medical condition: Surgical wound infection
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10048038 Wound infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-007712-14 Sponsor Protocol Number: 1120081 Start Date*: 2009-01-17
    Sponsor Name:Erasme Hospital
    Full Title: Monitoring of serum concentrations of posaconazole given as prophylaxis or therapy.
    Medical condition: fungal infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017533 Fungal infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2007-004611-61 Sponsor Protocol Number: DaPro Start Date*: 2008-08-19
    Sponsor Name:Medizinische Hochschule Hannover (MHH)
    Full Title: Prospektive, randomisierte, monozentrische 2-armige Studie zum Einsatz von Daptomycin in der antibiotischen Prophylaxe von sternalen Wundinfektionen nach medianer Sternotomie
    Medical condition: Incidence of sternal wound infections after cardiac surgery via median sternectomy and use of the heart-lung machine.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036410 Postoperative wound infection LLT
    9.1 10053562 Surgical wound infection LLT
    9.1 10054091 Wound infection due to staphylococcus aureus LLT
    9.1 10059442 Wound infection staphylococcal LLT
    9.1 10063528 MRSA wound infection LLT
    9.1 10065240 Wound infection bacterial LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-006435-13 Sponsor Protocol Number: 5065 Start Date*: 2008-10-15
    Sponsor Name:University of Southampton
    Full Title: GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).Workpackage 10: Antibiotic Trial One
    Medical condition: Lower Respiratory Tract Infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008477 Chest infection LLT
    9.1 10024968 Lower respiratory tract infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Completed)
    Trial results: View results
    EudraCT Number: 2017-000717-24 Sponsor Protocol Number: 230390 Start Date*: 2017-08-24
    Sponsor Name:Aarhus University Hospital
    Full Title: Concentration of piperacillin in plasma and subcutis in patients on crrt treatment
    Medical condition: infections reloated to CRRT
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000019640 10021804 Infection bacterial LLT
    20.0 100000015677 10021863 Infection respiratory LLT
    20.0 100000165071 10021867 Infection systemic LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-005736-17 Sponsor Protocol Number: NL56697.041.16 Start Date*: 2016-09-20
    Sponsor Name:University Medical Center Utrecht
    Full Title: Prevention of severe infectious complications after colorectal surgery using antimicrobial decontamination of the digestive tract (PreCaution trial)
    Medical condition: The medical condition under investigation: surgical site infections (bacterial) after elective colorectal surgery.
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004862 10053562 Surgical wound infection LLT
    19.0 100000004862 10056641 Post procedural site wound infection LLT
    19.0 100000004862 10074392 Deep postoperative wound infection LLT
    19.0 100000004862 10074393 Superficial postoperative wound infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-003717-33 Sponsor Protocol Number: P02095 Start Date*: 2005-09-13
    Sponsor Name:SCHERING-PLOUGH
    Full Title: Open-Label, limited access protocol of Posaconazole in invasive fungal infections.
    Medical condition: Profilaxys of invasive mycotic infections in high risk neutropenic patients.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10017533 PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-003092-39 Sponsor Protocol Number: PHARMACOLIS Start Date*: 2007-11-20
    Sponsor Name:CHU DE POITIERS
    Full Title: Pharmacokinetics of colistimethate and colistine after a 60 minutes intravenous infusion of colistimethate 1 million UI (80 mg) in 12 healthy volunteers
    Medical condition: kidney infection genital infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10023424 Kidney infection LLT
    9.1 10018152 Genital infection bacterial NOS LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-003690-25 Sponsor Protocol Number: PI2012_843_0008 Start Date*: 2013-01-23
    Sponsor Name:CHU Amiens
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004862 10061017 Bone infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001586-15 Sponsor Protocol Number: 5065 Start Date*: 2007-10-16
    Sponsor Name:University of Southampton
    Full Title: GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).Workpackage 10: Antibiotic Trial One
    Medical condition: Lower Respiratory Tract Infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008477 Chest infection LLT
    9.1 10024968 Lower respiratory tract infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) GB (Completed) BE (Completed) SE (Completed) ES (Completed) IT (Completed) DE (Completed) FR (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2004-001901-81 Sponsor Protocol Number: AISAR-01-04 Start Date*: 2004-07-23
    Sponsor Name:AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE
    Full Title: Efficacy and tollerability of thiamphenicol glycinate acetylcysteinate, given in sequential therapy sistematic and aerosol or by aerosol in the treatment of hight respiratory tract acute infectio...
    Medical condition: terapia sequenziale sistemica ed aerosol delle infezioni acute e/o subacute/ricorrenti delle alte vie respiratorie
    Disease: Version SOC Term Classification Code Term Level
    6.1 10004018 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-005045-38 Sponsor Protocol Number: Colistina Start Date*: 2007-10-02
    Sponsor Name:OSPEDALE POLICLINICO S. MATTEO
    Full Title: Pharmacokinetic and colimicine (ColistinaR) concentrations in broncho alveolar lavage in patients affected by pulmonary infections caused by Gram - bacteria.
    Medical condition: pulmonary disease caused by Gram - infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061229 Lung infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2012-001496-36 Sponsor Protocol Number: AMPISUL/AMOXICLAV-HD_V1.4 Start Date*: 2013-07-19
    Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme
    Full Title: Multiple-dose pharmacokinetics of ampicillin / sulbactam and amoxicillin / clavulanic acid during haemodialysis in longterm haemodialysis patients
    Medical condition: Suspected or proven bacterial infection requiring therapy with broad spectrum antibiotics
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10042196 Streptococcus pneumoniae secondary bacterial infection of acute bronchitis LLT
    14.1 10021881 - Infections and infestations 10053021 Gram-positive bacterial infection LLT
    14.1 10021881 - Infections and infestations 10035649 Pneumococcal secondary bacterial infection of acute bronchitis LLT
    14.1 10021881 - Infections and infestations 10004038 Bacterial infection due to streptococcus, group C LLT
    14.1 10021881 - Infections and infestations 10004039 Bacterial infection due to streptococcus, group D LLT
    16.0 10021881 - Infections and infestations 10004031 Bacterial infection due to other gram-negative organisms LLT
    14.1 10021881 - Infections and infestations 10004047 Bacterial infections NEC HLT
    14.1 10021881 - Infections and infestations 10060945 Bacterial infection PT
    14.1 10021881 - Infections and infestations 10004042 Bacterial infection due to unspecified streptococcus LLT
    14.1 10021881 - Infections and infestations 10004037 Bacterial infection due to streptococcus, group B LLT
    14.1 10021881 - Infections and infestations 10054278 Bacterial infection due to streptococcus, group F LLT
    14.1 10021881 - Infections and infestations 10004041 Bacterial infection due to unspecified staphylococcus LLT
    14.1 10021881 - Infections and infestations 10004036 Bacterial infection due to streptococcus, group A LLT
    14.1 10021881 - Infections and infestations 10004044 Bacterial infection NOS LLT
    14.1 10021881 - Infections and infestations 10004035 Bacterial infection due to staphylococcus aureus LLT
    14.1 10021881 - Infections and infestations 10004040 Bacterial infection due to streptococcus, group G LLT
    14.1 10021881 - Infections and infestations 10018657 Gram-negative bacterial infection NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004397-62 Sponsor Protocol Number: PI070274 Start Date*: 2008-11-28
    Sponsor Name:Servicio Andaluz de Salud
    Full Title: Análisis aleatorizado y doble ciego sobre la utilidad del extracto de arándano rojo vs profilaxis antibiótica con Trimetoprima en la infección urinaria recurrente infantil
    Medical condition: First clinical assay so far where the convenience is evaluated of carrying out prophylaxis of the pediatric urinary recurrent infection in the childhood with extract of cranberries (with a fixed co...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021872 Infection urinary tract LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-000443-27 Sponsor Protocol Number: KP-ELF01 Start Date*: 2012-06-12
    Sponsor Name:Dept. of Anesthesiology and Intensive Care, Charité - Campus Benjamin Franklin
    Full Title: Determination of the penetration of antibiotics into epithelial lining fluid during continuous infusion in mechanically ventilated ICU patients: example meropenem
    Medical condition: pneumonia complicated urinary infection complicated abdominal infection complicated skin and soft tissue infection acute bacterial meningitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10049582 Soft tissue infection NOS LLT
    20.0 100000004862 10040874 Skin infection NOS LLT
    20.0 100000004862 10046576 Urinary tract infection, site not specified LLT
    22.1 100000004862 10035725 Pneumonia NOS LLT
    20.1 100000004862 10056570 Intra-abdominal infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-001426-14 Sponsor Protocol Number: Preda Start Date*: 2009-03-02
    Sponsor Name:AZIENDA OSPEDALIERA PROVINCIALE DI LECCO
    Full Title: a probiotic for the prevention of diarrhoea associated with antibiotics
    Medical condition: Diarrheoa from AAD and CD
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004018 Bacterial infectious disorders HLGT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001321-25 Sponsor Protocol Number: 101596 Start Date*: 2004-05-19
    Sponsor Name:WYETH LEDERLE
    Full Title: A prospective, open label, monocenter trial to evaluate the interaction between the Platelia Aspergillus ELISA test and the administration of piperacillin/tazobactam.
    Medical condition: Evaluation of interference between platelia aspergillus ELISA TEST and administration of PIPERACILLIN/TAZOBACTAM.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10004018 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014387-20 Sponsor Protocol Number: DORI-PED-1003 Start Date*: 2009-10-23
    Sponsor Name:Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
    Full Title: An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants (Term and Preterm), Less Than 12 Weeks Chronological Age Protocol DORI-PED-1003;...
    Medical condition: hospitalized but medically stable infants (term and preterm), <12 weeks CA, who have documented, presumed to have, or are at risk for bacterial infection(s) and are undergoing treatment with i.v. a...
    Disease: Version SOC Term Classification Code Term Level
    12.0 10004044 Bacterial infection NOS LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed) GB (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2016-004486-37 Sponsor Protocol Number: 59812 Start Date*: 2017-09-19
    Sponsor Name:University Medical Centre Utrecht
    Full Title: FOsfomycin Randomised controlled trial for E.coli Complicated urinary tract infections as Alternative Stepdown Treatment
    Medical condition: Acute febrile urinary tract infection
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000017512 10046574 Urinary tract infection NOS LLT
    20.0 100000017512 10046576 Urinary tract infection, site not specified LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-004594-82 Sponsor Protocol Number: CSU11001 Start Date*: 2012-01-17
    Sponsor Name:Schur Pharmazeutika GmbH & Co. KG
    Full Title: Efficacy of an intravesical instillation with neomycin solution in acute cystitis: a double-blind, placebo-controlled trial in patients with permanent intravesical catheter
    Medical condition: Treatment of urinary tract infection
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10046571 Urinary tract infection PT
    14.1 10021881 - Infections and infestations 10046577 Urinary tract infections HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Apr 29 07:04:17 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA